scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1113355675 |
P356 | DOI | 10.1186/S40478-019-0712-8 |
P932 | PMC publication ID | 6456988 |
P698 | PubMed publication ID | 30971321 |
P50 | author | Morten Lund-Johansen | Q88316338 |
Rudi Beschorner | Q51727862 | ||
Rolf Bjerkvig | Q55223218 | ||
Terje Sundstrøm | Q59661601 | ||
P2093 | author name string | Katherine W Ferrara | |
Francisco Azuaje | |||
Frits Thorsen | |||
Kai Ove Skaftnesmo | |||
Elizabeth S Ingham | |||
Kjell Petersen | |||
Clifford G Tepper | |||
Lisa M Mahakian | |||
Gro Vatne Røsland | |||
Patrick N Harter | |||
Sarah Tam | |||
Yannick Braun | |||
Lars Prestegarden | |||
Karl Johan Tronstad | |||
Synnøve Nymark Aasen | |||
Simon Bernatz | |||
Jobin K Varughese | |||
Marzieh Bahador | |||
P2860 | cites work | Mitochondria, cholesterol and cancer cell metabolism | Q26741708 |
Plant sterols as anticancer nutrients: evidence for their role in breast cancer | Q26861053 | ||
Immunohistochemical testing of BRAF V600E status in 1,120 tumor tissue samples of patients with brain metastases | Q28250795 | ||
Mitochondrial respiration--an important therapeutic target in melanoma | Q28482377 | ||
Reduction of Serum Cholesterol with Sitostanol-Ester Margarine in a Mildly Hypercholesterolemic Population | Q29400323 | ||
Human breast cancer metastases to the brain display GABAergic properties in the neural niche | Q30569512 | ||
Accessory subunits are integral for assembly and function of human mitochondrial complex I. | Q32884468 | ||
Chemopreventive potential of beta-Sitosterol in experimental colon cancer model--an in vitro and In vivo study | Q33595208 | ||
Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis | Q33597162 | ||
Plant sterol and stanol margarines and health | Q33816769 | ||
A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia | Q34128023 | ||
Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group | Q34294096 | ||
Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer | Q34393640 | ||
Synergistic anti-cancer effect of phenformin and oxamate | Q34400208 | ||
Protection against esophageal cancer in rodents with lyophilized berries: potential mechanisms | Q34462618 | ||
Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
β-Sitosterol induces G1 arrest and causes depolarization of mitochondrial membrane potential in breast carcinoma MDA-MB-231 cells | Q35026335 | ||
Gain of glucose-independent growth upon metastasis of breast cancer cells to the brain | Q35044463 | ||
Cross-species hybridization of microarrays for studying tumor transcriptome of brain metastasis | Q35409064 | ||
Melanoma brain metastasis is independent of lactate dehydrogenase A expression | Q36082487 | ||
Oxidative stress inhibits distant metastasis by human melanoma cells | Q36277720 | ||
A randomised placebo-controlled trial of the efficacy of beta-sitosterol and its glucoside as adjuvants in the treatment of pulmonary tuberculosis | Q74259175 | ||
beta-Sitosterol activates the sphingomyelin cycle and induces apoptosis in LNCaP human prostate cancer cells | Q77587743 | ||
Strategies to optimize the brain availability of central nervous system drug candidates | Q84246366 | ||
A randomized trial of efficacy of beta-sitosterol and its glucoside as adjuvant to cryotherapy in the treatment of anogenital warts | Q87898498 | ||
The malignant melanoma landscape | Q88189060 | ||
Apoptotic effect of a phytosterol-ingredient and its main phytosterol (β-sitosterol) in human cancer cell lines | Q91330257 | ||
Molecular Profiling Reveals Unique Immune and Metabolic Features of Melanoma Brain Metastases | Q91759638 | ||
Phytosterols and risk of lung cancer: a case-control study in Uruguay. | Q53429729 | ||
Diet, nutrition intake, and metabolism in populations at high and low risk for colon cancer. Dietary cholesterol, beta-sitosterol, and stigmasterol. | Q55062592 | ||
New strategies in melanoma: entering the era of combinatorial therapy | Q56895974 | ||
New developments in brain metastases | Q64326768 | ||
Extrinsic factors can mediate resistance to BRAF inhibition in central nervous system melanoma metastases | Q36533041 | ||
Mechanisms limiting distribution of the threonine-protein kinase B-RaF(V600E) inhibitor dabrafenib to the brain: implications for the treatment of melanoma brain metastases | Q36642420 | ||
Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy | Q36698266 | ||
Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF. | Q36793719 | ||
Overcoming intrinsic multidrug resistance in melanoma by blocking the mitochondrial respiratory chain of slow-cycling JARID1B(high) cells | Q37260512 | ||
Multimodal imaging enables early detection and characterization of changes in tumor permeability of brain metastases | Q37579928 | ||
Roadblocks to translational advances on metastasis research | Q37679393 | ||
Brain metastases as preventive and therapeutic targets | Q37862581 | ||
Molecular drivers of cellular metabolic reprogramming in melanoma. | Q38331299 | ||
Drug repurposing in oncology--patient and health systems opportunities. | Q38611707 | ||
Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. | Q38737680 | ||
Survival of patients with metastatic melanoma and brain metastases in the era of MAP-kinase inhibitors and immunologic checkpoint blockade antibodies: A systematic review. | Q38774042 | ||
Bevacizumab Prevents Brain Metastases Formation in Lung Adenocarcinoma | Q38799510 | ||
Melanoma central nervous system metastases: current approaches, challenges, and opportunities | Q38807942 | ||
Updates in the management of brain metastases. | Q38887451 | ||
Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells | Q39156681 | ||
Automated tracking of nanoparticle-labeled melanoma cells improves the predictive power of a brain metastasis model | Q39191693 | ||
PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. | Q39193337 | ||
Incorporation of β-sitosterol into mitochondrial membrane enhances mitochondrial function by promoting inner mitochondrial membrane fluidity | Q39229653 | ||
Importance of glycolysis and oxidative phosphorylation in advanced melanoma | Q39264242 | ||
Dietary intake of plant sterols stably increases plant sterol levels in the murine brain | Q39405942 | ||
Plant sterols and risk of stomach cancer: a case-control study in Uruguay | Q39555740 | ||
A low-cost flow cytometric assay for the detection and quantification of apoptosis using an anionic halogenated fluorescein dye. | Q39942089 | ||
Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death. | Q40194409 | ||
Effect of resveratrol and beta-sitosterol in combination on reactive oxygen species and prostaglandin release by PC-3 cells. | Q40467772 | ||
beta-Sitosterol, beta-Sitosterol Glucoside, and a Mixture of beta-Sitosterol and beta-Sitosterol Glucoside Modulate the Growth of Estrogen-Responsive Breast Cancer Cells In Vitro and in Ovariectomized Athymic Mice | Q40561833 | ||
Phytosterols reduce in vitro metastatic ability of MDA-MB-231 human breast cancer cells | Q40737177 | ||
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors | Q40969918 | ||
In vitro and in vivo (SCID mice) effects of phytosterols on the growth and dissemination of human prostate cancer PC-3 cells | Q43934877 | ||
Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial | Q44442912 | ||
Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease | Q44605268 | ||
Beta-sitosterol inhibits cell growth and induces apoptosis in SGC-7901 human stomach cancer cells. | Q46004225 | ||
Dietary consumption of phytochemicals and breast cancer risk in Mexican women | Q46468802 | ||
Chemoprevention of tumor metastasis by liposomal beta-sitosterol intake | Q46725472 | ||
Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking | Q47828100 | ||
RNAi screen identifies essential regulators of human brain metastasis-initiating cells. | Q48001574 | ||
Adaptation of energy metabolism in breast cancer brain metastases | Q48269541 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | Cytoscape | Q3699942 |
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | brain metastasis | Q1620196 |
BRAF V600E | Q21851559 | ||
P304 | page(s) | 55 | |
P577 | publication date | 2019-04-10 | |
P1433 | published in | Acta Neuropathologica Communications | Q27724912 |
P1476 | title | Inhibition of mitochondrial respiration prevents BRAF-mutant melanoma brain metastasis | |
P478 | volume | 7 |